Meet Our Members

Andrew Geall

Replicate Bioscience

Chief Development Officer

Anshul Mangal

Project Farma and Precision ADVANCE

President

Baley Reeves, Ph.D.

National Center for Therapeutics Manufacturing Texas A&M Engineering

Interim Director

Breton Hornblower, Ph.D.

New England Biolabs

Portfolio Manager, Regulated Markets

Chris Murphy

Akron Biotech

Chief Executive Officer

Daria Donati

Danaher

Chief Scientific Officer, Genomic Medicine, Cytiva

David Butler

Hongene Biotech

Chief Technology Officer

Dominika Nowis, MD, PhD

ExploRNA Therapeutics

Dr Gisela Mautner

Noxopharm

Chief Executive Officer and Managing Director

Dr. Thomas Madden

Acuitas Therapeutics, Inc.

President & CEO

Enrico Steiner

Thermo Fisher Scientific

Site Leader, mRNA

Guillaume Roelandts

Quantoom Biosciences

Head of Products & Marketing

Helge Zieler, PhD

Primrose Bio

CEO

Jeff Coller, PhD

Director, Hopkins RNA Innovation Center

Bloomberg Distinguished Professor of RNA Biology and Therapeutics

Joel Harris

Genvax Technologies

CEO and Co-founder

Kate Broderick

Maravai Life Sciences

Chief Innovation Officer

Marco Pupo

Anemocyte

Innovation and Development Supervisor

Melanie Cerullo 

ReciBioPharm

Chief Quality & Regulatory Officer

Patrick Thiaville, Ph.D

Exothera

Chief Technology Officer - Nucleic Acids

Patty Limphong, PhD

SoCal Biosciences, Inc.

CEO, President & Founder

Professor KOH Boon Tong

Nucleic Acid Therapeutics Initiative (NATi)

Executive Director

Professor Timothy Mercer

University Of Queensland

Director, BASE

Remo Moomiaie-Qajar, M.D.

Cytonus

CEO

Sarit Schwartz, PhD

Ginkgo Bioworks

Director, Head of RNA Business Development

Shehnaaz Suliman, M.D., M.B.A., M.Phil.

ReCode Therapeutics

Chief Executive Officer

Vicent J. Nebot

Curapath

Chief Technical Officer

Ye Zhang

Arcturus Therapeutics

Senior Vice President, Head of Regulatory Affairs